Clinical Trials Logo
  1. Home
  2. Detrusor Overactivity
  3. NCT01850706

UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation

Detrusor Overactivity Clinical Trial

Official title:
Evaluation of Urinary Nerve Growth Factor as an Objective Tool to Assess Therapeutic Outcome in Patients With Detrusor Overactivity Undergoing Treatment With Sacral Neuromodulation

Clinical Trial Summary

The purpose of this study is to find a noninvasive test to help physicians diagnose detrusor overactivity (DO), to use this urine test to help diagnose bladder problems, determine if treatments are working, and determine if patients are good candidates for interventions like sacral neuromodulation/Interstim Therapy.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01850706
Study type Observational
Source Northwell Health
Contact
Status Completed
Phase N/A
Start date August 2011
Completion date March 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT04543552 - A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
Completed NCT04978714 - USI and/or DO in Women With Cystocele Before and After Cystocele Repair
Not yet recruiting NCT04693897 - Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker
Enrolling by invitation NCT00822913 - Botulinum A Toxin in Patients With Parkinson's Disease Phase 4
Terminated NCT00373789 - Refractory Urge Incontinence and Botox Injections Phase 3
Completed NCT01093534 - Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. Phase 4
Completed NCT01003457 - Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity N/A
Terminated NCT01023269 - Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder N/A
Not yet recruiting NCT05572918 - Developing a Simple Test to Diagnose Overactive Bladder
Completed NCT00478881 - A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function Phase 2
Completed NCT00678795 - A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis Phase 3